Refractory warts: topical or intralesional cidofovir options

Published Date: 02 Mar 2023

New research suggests that cidofovir may be a helpful option for tender joints or joints.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Trump slashed US cancer research by 31 percent: Senate report

2.

PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.

3.

A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.

4.

FDA approves rivanetin as the first-line treatment for lung cancer.

5.

Black women are more likely to die of breast cancer. Close the gap by looking into mammogram studies.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot